Scarica l'app Stockscreener
12.59
4.48%
-0.59
Dopo l'orario di chiusura:
12.59
Precedente Chiudi:
$13.18
Aprire:
$13.18
Volume 24 ore:
282.66K
Relative Volume:
1.02
Capitalizzazione di mercato:
$655.03M
Reddito:
-
Utile/perdita netta:
$-41.43M
Rapporto P/E:
-15.94
EPS:
-0.79
Flusso di cassa netto:
$-39.97M
1 W Prestazione:
-3.89%
1M Prestazione:
-2.33%
6M Prestazione:
+45.38%
1 anno Prestazione:
+72.70%
Intervallo 1D:
$12.26
$13.18
Intervallo di 1 settimana:
$12.26
$13.65
Portata 52W:
$6.72
$20.50
Gh Research Plc Stock (GHRS) Company Profile
Confronta GHRS con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
GHRS
Gh Research Plc
|
12.59 | 817.55M | 0 | -41.43M | -39.97M | -0.79 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.79 | 106.37B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
460.46 | 59.90B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
564.63 | 60.40B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
796.92 | 49.56B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.10 | 36.88B | 4.56B | -176.77M | 225.30M | -1.7177 |
Gh Research Plc Stock (GHRS) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-06-04 | Ripresa | Cantor Fitzgerald | Overweight |
| 2025-03-13 | Iniziato | Guggenheim | Buy |
| 2025-03-07 | Iniziato | RBC Capital Mkts | Outperform |
| 2025-02-13 | Iniziato | Cantor Fitzgerald | Overweight |
| 2022-08-16 | Iniziato | H.C. Wainwright | Buy |
| 2022-06-16 | Iniziato | ROTH Capital | Buy |
Mostra tutto
Gh Research Plc Borsa (GHRS) Ultime notizie
How GH Research PLC stock responds to policy changesJuly 2025 Trends & AI Driven Price Forecasts - newser.com
Signal strength of GH Research PLC stock in tech scannersMarket Risk Report & Verified Short-Term Plans - newser.com
GH Research Presents Promising GH001 Trial Data at ECNP 2025 - TipRanks
Can a trend reversal in GH Research PLC lead to recoveryRisk Management & Risk Managed Trade Strategies - newser.com
GH Research Announces Novel Therapies Symposium Presentation and Posters at the 2025 ECNP Congress - GlobeNewswire
GH Research PLC stock momentum explainedMarket Sentiment Report & Free Daily Entry Point Trade Alerts - newser.com
GH Research Showcases Promising Depression Treatment at ECNP 2025 - TipRanks
GH Research PLC Announces Acceptance of Presentation and Posters on GH001 for Treatment-Resistant Depression at ECNP Congress - Quiver Quantitative
No treatment-related SAEs: GH Research 6‑Month GH001 safety & psychoactive data for TRD at ECNP 2025 - Stock Titan
Will GH Research PLC stock outperform international peers2025 Historical Comparison & AI Powered Buy and Sell Recommendations - newser.com
Using fundamentals and technicals on GH Research PLCJuly 2025 Action & Weekly High Potential Alerts - newser.com
GH Research's (GHRS) Sell (D-) Rating Reiterated at Weiss Ratings - MarketBeat
Market reaction to GH Research PLC’s recent newsWeekly Trend Summary & Risk Controlled Daily Trade Plans - newser.com
Can volume confirm reversal in GH Research PLCQuarterly Risk Review & High Win Rate Trade Alerts - newser.com
Has GH Research PLC found a price floorJuly 2025 Summary & Real-Time Volume Analysis Alerts - newser.com
Does GH Research PLC qualify in momentum factor screeningMarket Activity Summary & Safe Investment Capital Preservation Plans - newser.com
Is GH Research PLC stock cheap at current valuationBuy Signal & Verified Swing Trading Watchlists - newser.com
Will GH Research PLC stock benefit from automationWall Street Watch & Low Drawdown Investment Ideas - newser.com
Why millennials buy GH Research PLC (1KA) stockJuly 2025 Fed Impact & AI Driven Price Forecasts - newser.com
Is GH Research PLC stock a buy in volatile markets2025 Top Gainers & Reliable Volume Spike Trade Alerts - newser.com
What drives GH Research PLC 1KA stock priceMonthly Performance Summary & Free Smart Trading Classes - earlytimes.in
H.C. Wainwright maintains buy on GH Research stock, $40 target - MSN
Gh Research Plc Azioni (GHRS) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
5.74%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):